Building Empowerment and Coping Outcomes for CaNcer Patients, Survivors and Their Caregivers (BEACON)

January 27, 2025 updated by: Color Health, Inc.

BEACON Study: Virtual Coping Skills Groups for Cancer Patients, Survivors and Their Caregivers

Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cancer has a psychological, emotional and social impact beyond a patient's physical health. These problems often ripple beyond the individual with the diagnosis, to their broader community, and also beyond a cancer treatment course into survivorship. As a result, there are a wide range of socioemotional needs in those who have been impacted by cancer. Further, these emotional impacts have a direct impact on morbidity and mortality of cancer. A new peer mental-wellness support program, called Color Cancer Connect (CCC) supports cancer patients, survivors and their caregivers by teaching them evidence-based skills to manage the emotional impact of cancer. This study will examine all three programs (i.e., patient, survivor, caregiver) to gather data to measure the impact of the program on emotional well-being, quality of life and health behaviors.

Study Type

Interventional

Enrollment (Actual)

133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Burlingame, California, United States, 94010
        • Color Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Lived experience as either a current cancer patient, cancer survivor or caregiver of someone with cancer
  • Adult - 18+
  • Has health insurance provided by employer or union (can be dependent of person on insurance)
  • Read/speak English
  • Have access to internet and personal email account

Exclusion Criteria:

  • Severe mental illness that is disruptive to other group members

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cancer Connect Program
Participants assigned to this arm will be able to attend the online peer program upon entering the study.
Behavioral: Cancer Connect Program
Online group peer program where participants learn evidence based skills for managing stressors and emotions related to their cancer experience.
Placebo Comparator: Waitlist
Participants assigned to this arm will be on a waitlist and will be invited to join the online peer program in 3 months.
Behavioral: Cancer Connect Program
Online group peer program where participants learn evidence based skills for managing stressors and emotions related to their cancer experience.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: Multiple time points across 8 months (waitlist; baseline, 2 months post waitlist, 3 months post waitlist, 2 months post program start, 3 months post program start) or 5 months (intervention; baseline, 2 months post program start, 3 months post program)
Patient Health Questionnaire-9 (PHQ-9)
Multiple time points across 8 months (waitlist; baseline, 2 months post waitlist, 3 months post waitlist, 2 months post program start, 3 months post program start) or 5 months (intervention; baseline, 2 months post program start, 3 months post program)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Color Health, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2024

Primary Completion (Actual)

January 25, 2025

Study Completion (Actual)

January 25, 2025

Study Registration Dates

First Submitted

April 2, 2024

First Submitted That Met QC Criteria

April 5, 2024

First Posted (Actual)

April 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 27, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20240314

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Cancer Connect Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe